During the crisis, growing demand, insufficient production, and national stockpiling of essential products such as personal protective equipment (PPE), pharmaceuticals and medical goods, caused shortages in the EU and beyond. So, what are the chances and risks of diversifying supply chains and reshoring production?
Will European consumers be willing to pay the (higher) price? How dependent are European markets on other regions? And, what measures must be taken to make international supply- and value chains more crisis-proof and independent?